ClinicalTrials.Veeva

Menu

COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort (VaxiRIS)

C

Centre Hospitalier Universitaire de Nice

Status

Completed

Conditions

COVID-19
Multiple Sclerosis

Treatments

Other: NO intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05387395
22Neuro02

Details and patient eligibility

About

The Radiologically Isolated Syndrome (RIS) is defined as incidental Magnetic Resonance Imaging (MRI) abnormalities fulfil the criteria for dissemination in space, suggestive of multiple sclerosis. Nowadays, mandatory vaccination in patients with multiple sclerosis (MS) is widely recommended. Regarding COVID19, the absence of specific warnings led to the proposal of vaccination in patients with inflammatory diseases of the central nervous system. We aimed to evaluate if COVID19 vaccination or infection increased the risk of clinical conversion to multiple sclerosis or evidence of disease activity (EDA) in a cohort of RIS subjects.

Enrollment

217 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients belong to the RISC cohort;
  • totally vaccinated ou partially vaccinated patient
  • vaccination status known

Exclusion criteria

  • presented a first clinical event before the COVID19 vaccination

Trial design

217 participants in 2 patient groups

complete vaccination
Description:
Complete vaccination was defined as administering two doses of mRNA or AstraZeneca vaccine, administration of one dose of Jansen vaccine, or administration of one dose of any vaccine in patients with a history of COVID19 infection.
Treatment:
Other: NO intervention
incomplete vaccination
Description:
Other cases were defined as incomplete or absent vaccination.
Treatment:
Other: NO intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems